Amy Trombly

Insider Reports History

Entity
Individual
Location
1314 Main Street, Suite 102, Lousiville, CO
Signature
/s/ Amy Trombly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amy Trombly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sonoma Pharmaceuticals, Inc. Chief Executive Officer Stock option (right to buy) 174K Dec 29, 2023 Direct
Sonoma Pharmaceuticals, Inc. Chief Executive Officer Common Stock, $0.0001 par value 154K Jun 20, 2024 Direct

Insider Reports Filed by Amy Trombly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNOA Sonoma Pharmaceuticals, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Chief Executive Officer
SNOA Sonoma Pharmaceuticals, Inc. Dec 29, 2023 1 $0 4 Dec 29, 2023 Chief Executive Officer
SNOA Sonoma Pharmaceuticals, Inc. Jun 30, 2023 1 $0 4 Jul 3, 2023 Chief Executive Officer
SNOA Sonoma Pharmaceuticals, Inc. Dec 29, 2022 1 $0 4 Dec 30, 2022 Chief Executive Officer
SNOA Sonoma Pharmaceuticals, Inc. Jan 14, 2022 1 $0 4 Jan 14, 2022 Chief Executive Officer